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Listeria monocytogenes is an opportunistic foodborne pathogen causing listeriosis, an often fatal infection leading to meningitis,
sepsis, or infection of the fetus and abortion in susceptible individuals. It was recently found that the bacterium can also cause
acute, self-limiting febrile gastroenteritis in healthy individuals. In the intestinal tract, L. monocytogenes penetrates the mucosa
directly via enterocytes, or indirectly via invasion of Peyer’s patches. Animal models for L. monocytogenes infection have provided
many insights into the mechanisms of pathogenesis, and the development of new model systems has allowed the investigation
of factors that inﬂuence adaptation to the gastrointestinal environment as well as adhesion to and invasion of the intestinal
mucosa. The mucosal surfaces of the gastrointestinal tract are permanently exposed to an enormous antigenic load derived from
the gastrointestinal microbiota present in the human bowel. The integrity of the important epithelial barrier is maintained by
the mucosal immune system and its interaction with the commensal ﬂora via pattern recognition receptors (PRRs). Here, we
discuss recent advances in our understanding of the interaction of L. monocytogenes with the host immune system that triggers the
antibacterial immune responses on the mucosal surfaces of the human gastrointestinal tract.
1.Introduction
Listeria monocytogenes is a Gram-positive foodborne path-
ogen that is ubiquitously found in diverse environments
such as soil, water, various food products, animals, and
humans [1]. Infection by Listeria monocytogenes occurs
almost exclusively after ingestion of contaminated food.
Because the bacteria are readily inactivated at pasteuriza-
tion temperature, the main source of infection represents
contaminated raw food that is subjected to minimal fur-
ther processing, such as soft cheeses, frankfurters, pˆ at´ es,
vegetables and postprocessed contaminated milk products
[2]. In individuals with impaired cell-mediated immunity
such as neonates, pregnant woman, elderly persons, and
immunocompromised patients suﬀering from transplan-
tation events, the bacterium may cause mother-to-fetus
infections, septicemia, or meningoencephalitis. Listeriosis
is relatively rare and annual incidence is decreasing; in
the United States from 7.7 cases per million population
in 1990 to 3.1 cases per million population in 2003. In
France, the incidence of listeriosis declined from 4.5 cases
per million population in 1999–2000 to approximately 3.4
in 2002–2003 [3]. Although the incidence is low, the high
mortality rates (about 30%) associated with listeriosis make
L. monocytogenes one of the most deadly human food-borne
pathogens. In contrast to the severe invasive disease recent
outbreaks demonstrated that infection of healthy individuals
with L. monocytogenes often leads to the development of a
febrile gastroenteritis [4].
The organisms are well adapted to the conditions in
the gastrointestinal tract and pursue diﬀerent strategies to
counteract changes in acidity, osmolarity, oxygen tension, or
thechallengingeﬀectsofantimicrobialpeptidesandbile.The
ﬁnding that the bacteria are able to colonize and persist in
the gallbladder [5] suggests the occurrence of long-term and
chronicinfectionsanddemonstratestheabilityofpathogenic
Listeria to survive within the various microenvironments of
the gastrointestinal tract.
Although other animals, such as guinea pigs, seem
to be better suited to study the immune response to2 International Journal of Inﬂammation
L. monocytogenes mice have been proven the most useful
model for immunological studies due to availability of
knock-out mice deﬁcient in speciﬁc genes. Hence, most
of our knowledge of how the immune system functions
has been learned from experimental infections of mice
using L. monocytogenes and the subsequent analysis of the
innate and adaptive immune responses [6]. The molecules
that function as pattern recognition receptors (PRRs) on
epithelial cells, macrophages, and dendritic cells (DCs),
thereby triggering the innate immune system after contact
to bacterial pathogens, comprise Toll-like receptors (TLRs)
andnucleotide-bindingoligomerizationdomain(NOD)-like
receptors (NLRs). The recognition of pathogen-associated
molecular patterns (PAMPs) by the PRRs on mucosal cells
drivestheactivationofsubsequentsignalingcascadesinclud-
ing NF-κB, interferon (IFN) response factors (IRFs), activa-
tor protein 1 (AP1), and mitogen-activated protein kinases
that promote the induction of proinﬂammatory cytokines
and antimicrobial peptides, as well as the maintenance of
epithelial barrier function and epithelial cell proliferation
[7]. The vast amount of knowledge that has been gathered
through proteomic and transcriptomic approaches makes L.
monocytogenes one of the best-studied bacterial pathogens
for investigations on the interplay of intracellular pathogens
and the intestinal immune system. In this paper, we focus
on the recent developments in the analysis of the interaction
between L. monocytogenes and the mucosal immune system
of the host gastrointestinal tract.
2. Adaptation of Listeria monocytogenes to
the Conditions of the GI Tract
Along the gastrointestinal tract L. monocytogenes cells have
to face a hostile environment characterized by altered
osmolarity, low oxygen pressure, low pH, and presence of
bile. In a recent article Lungu et al. [8] reconsider growth,
survival, proliferation and pathogenesis of L. monocytogenes
under low oxygen or anaerobic conditions. Other studies
have shown that L. monocytogenes is able to launch acid
resistance systems to respond to the low pH conditions in
foodorinthehost[9,10].InL.monocytogenes,theglutamate
decarboxylase (GAD) system confers resistance to acidic
environments. Cotter and colleagues demonstrated that the
expression of the GAD system correlates directly with acid
tolerance of L. monocytogenes a n di sa na b s o l u t er e q u i r e m e n t
for survival during the transmission of the stomach [9].
This system has already been associated with acid resistance
in many other bacteria that need to transit the stomach
before they reach their site of infection. The GAD system
leads to intracellular consumption of protons by irreversible
decarboxylation of extracellularly sourced glutamate and
subsequent export of gamma-aminobutyrate (GABA) via
a glutamate:GABA antiporter. Surprisingly, it was shown
that acid-adapted L. monocytogenes were more successful in
entering and proliferating in Caco-2 cells in contrast to cells
that were not previously exposed to acid-stress [11].
L. monocytogenes encounters changes in the osmolarity
not only in the gastrointestinal tract of its host but also
in the food industry, as a preservation method or in their
environmental niches. The strategy that Listeria and also
other bacteria apply to respond to conditions of elevated
osmolarity is the cytoplasmic accumulation of compatible
solutes or osmolytes (reviewed by Sleator and Hill [13]).
The ﬁnding that L. monocytogenes is able to colonize the
gall bladder of infected mice demonstrates the organisms
abilities to tolerate high concentrations of bile stored in this
compartment [14]. The genes conferring the principal bile-
resistance to L. monocytogenes are BSH and BilE [5]. This
resistance has important consequences as Dussurget et al.
[15]reportedthatbilesalthydrolaseactivityisessentialforL.
monocytogenes pathogenesis. Furthermore, carnitine uptake
by the pathogen is essential for survival in the small intestine
and transient colonization of the murine gastrointestinal
tract [16, 17].
In the context of adaptation of L. monocytogenes to the
conditionsalongtheGItract,thetranscriptionfactorSigma
B
(σB)wasidentiﬁedasthekeyfactorthattriggersthemanifold
adaptation mechanisms. The crucial role that the σB protein
plays in acid-tolerance was identiﬁed by Wiedmann et al.
[18], whereas Becker et al. [19] independently identiﬁed σB
as the relevant factor for adaptation of L. monocytogenes to
alterationsinosmolarityandtemperature.Also,thegenesfor
BSH and BilE responsible for bile-tolerance are preceded by
σB dependent promoter sites [5, 20].
In their study, Kazmierczack et al. [21] identiﬁed ﬁfty-
ﬁve genes showing a statistically signiﬁcant σB dependent
expression after exposure of L. monocytogenes to osmotic
stress. In a more recent study by Hain et al. [22], the
authors report a signiﬁcantly higher number of genes that
were under the regulation of σB. They found 111 genes
under negative control of σB and 105 genes that showed a
positive σB dependent regulation. In L. monocytogenes σB
contributes to both stationary- and exponential-phase acid
resistance, whereas in L. innocua acid resistance is conferred
by σB only during the exponential-phase of growth [23].
Thus, the function of σB seems to be strain and species
dependent within the genus Listeria. Moreover, it turned out
that diﬀerent serotypes of L. monocytogenes reveal diﬀerences
in their dependency on a functional σB regulon [24]. As
a consequence, the resulting variations in environmental
stress resistance may oﬀer an explanation for the reported
diﬀerences in the virulence traits and the survival capabilities
in the host and in food for diﬀerent L. monocytogenes strains
[18]. The obtained results indicate that σB contributes to
L. monocytogenes survival not only in environmental niches
but also inside the host [25, 26]. This is emphasized by
the ﬁnding that σB is required for the expression of the
manifold genes that are important for the survival of L.
monocytogenes within the GI tract of a host. In fact, the
σB regulon comprises important virulence genes, encoding
virulence factors such as internalin A and B [21, 22]. In
murine and guinea pig models, loss of σB function has been
shown to result in decreased virulence of L. monocytogenes
after oral infection but not during systemic infection [27].
Furthermore, L. monocytogenes show an up-regulation of
the sigB gene during passage of the mouse GI tract [5].
Hence, the alternative sigma factor σB represents a crucialInternational Journal of Inﬂammation 3
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Figure 1: Stages in the intracellular life cycle of L. monocytogenes. The cartoon (a) sketches the diﬀerent stages of L. monocytogenes infection:
(I) cell entry mediated by invasion factors InlA or INLB, (II) escape from phagolysosom by LLO and PlcA, (III) actin recruitment and
replication, (IV) intracellular movement due to polarized actin-polymerization mediated by ActA, (V) cell-to-cell spread by formation
of listeriapods, and (VI) subsequent lysis of the two-membrane vacuole by LLO and PlcB. Modiﬁed from Tilney & Portnoy [12]. The
ﬂuorescence image (b) shows the intracellular movement and cell-to-cell spread of L. monocytogenes cells (green) driven by the polarized
polymerization of actin tails (red).
prerequisite for the successful infection of a host by Listeria
monocytogenes via the GI route (Figure 1).
3. Gastroenteritisdue toListeria
monocytogenes
Listeriosis is a severe foodborne disease characterized by
bacteremia and meningoencephalitis in individuals with
impaired cell-mediated immunity, including neonates, preg-
nant woman, elderly persons, and immunosuppressed
patients. The incidence of listeriosis is rather low, compared
to other common foodborne pathogens such as Campy-
lobacter species, Salmonella species, Shigella species, and
Vibrio species. However, the outcome is much more severe
and often fatal. In fact, it represents one of the most
deadly bacterial infections due to its high mean mortality
rate of 20%–30%, despite early antibiotic treatment [28].
Ingestion of food contaminated with L. monocytogenes
is the usual mode of transmission leading to listeriosis.
Although many patients experience diarrhea antecedent to
the development of bacteremia or meningoencephalitis due
to L. monocytogenes infection, it was only recently that
convincing evidence was obtained that L. monocytogenes can
cause self-limiting, febrile gastroenteritis in healthy persons
[4]. Atleastsevenoutbreaks of foodborne gastroenteritis due
toL.monocytogenesinfectionhavebeenreportedoverthelast
20 years (Table 1). First evidence was obtained in 1989 when
the L. monocytogenes strains isolated from blood samples
of two febrile pregnant women and those from the stool
samples of a person with diarrhea were shown to be identical
[29].Allthreepatientsattendedthesameparty,andatotalof
17 of the 36 attendees reported gastrointestinal complaints.
More convincing evidence that L. monocytogenes could cause
self-limiting gastroenteritis came from an outbreak of febrile
gastroenteritis that was associated with the consumption
of contaminated chocolate milk [30]. A total of 45 out
of 60 persons who drank chocolate milk served in the
course of a picnic developed the symptoms, and identical
strains were obtained from 14 symptomatic patients, from
unopened cartons of the chocolate milk, as well as from the
environment of the dairy that supplied the milk [30]. One of
the largest documented outbreaks of febrile gastrointestinal
illness comprised 292 persons who had been hospitalized
after eating in the cafeteria of two primary schools in
northern Italy in 1997. The contaminated food was prepared
by the same caterer and cultures from 123 stool samples
and 1 blood sample from the hospitalized patients turned
out to be indistinguishable to strains isolated from the food,
and environmental specimens of the catering plant [31].
Therefore, L. monocytogenes should be considered to be a
possible etiologic agent in outbreaks of febrile gastroenteritis
when routine cultures fail to yield a pathogen.
Common symptoms observed in the eﬀected patients
included fever, watery diarrhea, nausea, headache, and pain
injointsandmuscles.ThemechanismbywhichL.monocyto-
genes causes diarrhea is not entirely clear. However, it is likely
that it is the result of direct invasion of the epithelial cells
of the intestinal mucosa, as it is not known that L. monocyto-
genesproducesenterotoxins[4].Theobservedsymptomslike
fever as well as occasionally bloody diarrhea and bacteremia
further support the hypothesis that diarrhea results from
direct invasion of L. monocytogenes to the intestinal mucosal
epithelium. The observation that L. monocytogenes could
cause self-limiting, febrile gastroenteritis demonstrates that
the pathogen induces mucosal inﬂammation after entering
the host intestinal mucosa.
4. Adherence and Invasionof
the GastrointestinalEpithelium
There exist two principle mechanisms by which L. mono-
cytogenes can enter into the host through the intestinal
mucosa. The ﬁrst route is direct invasion of the enterocytes
lining the absorptive epithelium of the microvilli, leading4 International Journal of Inﬂammation
Table 1: Outbreaks of gastroenteritis due to Listeria monocytogenes.
Year of outbreak Number of cases Serotype Implicated source Reference
1993 18 1/2b Rice salad [41]
1994 45 1/2b Chocolate milk [30]
1997 1566 4b Cold-corn-and-tuna salad [31]
1998 5 1/2a Cold smoked trout [42]
2000 32 1/2 Corned beef and ham [43]
2001 16 1/2a Delicatessen meat [44]
2001 48 1/2a Cheese [45]
to infection of the intestinal cells. This entry mechanism
occurs only in humans and some susceptible animals (e.g.,
guinea pigs) that also express the correct isoform of the
receptor molecules necessary for recognition by the Listeria
invasion molecules, termed internalins [32]. The second
entry pathway is translocation across the M-cells of Peyer’s
patches[33].Thismechanismoccursalsoinhoststhatdonot
express susceptible isoforms of the receptor molecules, such
as mice and rats, and represents an unspeciﬁc mechanism
as nonpathogenic species such as L. innocua or Bacteroides
thetaiotaomicron, a prominent gut symbiont, are translo-
catedequally.However,thelattermechanismseemstobeless
eﬃcient than direct invasion of enterocytes [34].
As a ﬁrst step towards invasion of the gastrointestinal
epithelium the bacteria need to adhere to the surface of
the epithelial cells. To enable contact with the epithelium
underlying the mucus layer as the site of invasion many
bacteria produce mucinases. This is not the case for L.
monocytogenes which does not produce mucinases but a
number of surface proteins that can bind to a speciﬁc type
of human mucin [35]. Interaction with the human Muc2
isoform occurs trough the internalin proteins InlB, InlC, and
InlJ. This initial interaction is thought to be an important
prerequisite for the subsequent events leading to adherence
and invasion of the epithelial layer [28, 36]. For various
gastrointestinal pathogens, it is known that they use their
ﬂagellarstructuresnotonlyaseﬀectorsofmotilitybutalsoas
adhesins or as a secretion apparatus. This is also not the case
for L. monocytogenes which uses ﬂagella simply for motility
thereby increasing the eﬃcacy of host invasion [37, 38].
The initial interaction of internalins with Muc2 seems
not to be suﬃcient and further expression of proteins is
necessary to warrant adherence of the pathogen to the
epithelium. Listeria adhesion protein (LAP) was shown to
bind to the host cell heat-shock protein 60 [39]a n das p e c i ﬁ c
ﬁbronectin-binding protein (FbpA) of L. monocytogenes was
identiﬁed to interact with cell surface ﬁbronectin in the
murine model [40].
CentralforthepathophysiologyofListeriamonocytogenes
inthegastrointestinaltractistheabilitytocrosstheintestinal
barrier through invasion of enterocytes. This important
event is promoted by internalin A (InlA), whereas internalin
B (InlB) seems to play no direct role in invasion of cells of
the gastrointestinal epithelial layer. Instead, InlB is known
to mediate the invasion of hepatocytes and is required for
the infection of the fetoplacental unit [46, 47]. The cellular
receptor for InlA is human E-cadherin, a protein expressed
at the basolateral surface of polarized enterocytes that was
identiﬁed by aﬃnity chromatography on an InlA-column
[48]. The InlA E-cadherin interaction is species-speciﬁc, and
was shown to rely on a single amino acid residue in the E-
cadherinmolecule,whichisprolininpermissivespeciessuch
as humans, and glutamic acid in nonpermissive species such
as the mouse [34]. Although the E-cadherin of mouse and
human show about 85% similarity, InlA does not interact
with mouse E-cadherin. For this reason, mice are not an
appropriate experimental model for oral infection with L.
monocytogenes and the investigation of the pathogenic events
that enable the organisms to penetrate the intestinal mucosa
after ingestion of contaminated food. Consequently, the
necessity for further animal models for human listeriosis led
to the identiﬁcation of two novel and complementary animal
models. While gerbils turned out to be a natural host for
L. monocytogenes, a transgenic mouse line was developed
that features expression of human E-cadherin in enterocytes
[49].Useofthisanimalmodelconclusivelydemonstratedthe
role of InlA for crossing the intestinal barrier [34], and the
essential and interdependent roles of InlA and InlB in feto-
placentallisteriosis[46].Thedetailedmolecularmechanisms
ofInlAmediatedcellentryhavebeendescribedandreviewed
elsewhere [1, 50–53].
Upon uptake, the intracellular pathogen appears sur-
rounded by the membranes of the phagocytic vacuole.
Diﬀerentphospholipases(PI-PlcAandPI-PlcB)areactivated
by a metalloprotease (Mpl), and cooperate with the pore-
forming hemolysin listeriolysin O (LLO), which is most
active at the acidic conditions (pH 5.5) of the vacuole, to
confer the lysis of the phagosome membrane [54, 55]. Once
the bacteria escape into the cytoplasm, they start to replicate
while making use of speciﬁc transporter systems to gain
carbohydrates from the host cell [56].
At the same time the pathogen is released from the
phagosome, it induces the expression of ActA, a protein that
triggers the nucleation and polymerization of host globular
g-actin into f-actin ﬁlaments. The polarized polymerization
of actin leads to a propulsive force that propels the bacteria
through the cytoplasm and occasionally into the cytoplasma
membrane of neighboring cells. The resulting pseudopods
or “listeriapods” are then taken up (endocytosed) by the
adjacent cells, thus, promoting cell-to-cell spread of the
pathogen from on cell to another. The bacteria entrapped
within the double membrane of the newly infected vacuoleInternational Journal of Inﬂammation 5
are again released by the combined action of LLO and the
phospholipases, in this case the product of the plcB gene.
This invasion mechanism allows L. monocytogenes to safely
spreadthroughhosttissueswithoutleavingthehostcytosolic
compartment, thereby protected from the host adaptive
immune system. This intriguing strategy has been elucidated
and thoroughly reviewed elsewhere [1, 32, 56, 57].
5. InnateImmune Responses to
Listeria monocytogenes
After infection within the gastrointestinal tract, immediate
immune responses are essential for the control of pathogens,
such as L. monocytogenes. Activation of the innate immune
system is triggered when pathogen-associated molecular
patterns (PAMPs) engage pattern recognition receptors
(PRRs) on intestinal epithelial cells (IECs) [58]. Despite the
given name, PAMPS are actually not restricted to pathogens.
They are expressed by all bacteria, invasive pathogens as
well as noninvasive commensals. Typical PAMPs include
bacterial carbohydrates, such as lipopolysaccharide (LPS),
mannose,nucleicacids(bothDNAandRNA),peptidoglycan
components, lipoteichoic acids, and probably many other
molecules, and are able to trigger the innate immune
response. Innate immunity to L. monocytogenes is primarily
mediated by two types of pattern recognition receptors,
the Toll-like receptors (TLRs), and the nucleotide-binding
oligomerization domain (NOD)-like receptors (NLRs). In
addition, there is some experimental evidence for the
involvementofscavengerreceptorsandaTLR-9independent
cytosolic sensor system for bacterial DNA [59].
Toll-like receptors (TLRs) are a family of transmembrane
glycoproteins, of which 10 members are known to exist in
humans, where they are located on the cell surface or within
endosomes. Upon recognition of the presence of microbes
through sensing pathogen-associated molecular patterns,
TLRs can bind any of the 4 known activating adaptors:
(i) Myeloid diﬀerentiating factor-88 (MyD88), (ii) MyD88
adapter-like (Mal), (iii) TIR domain-containing adapter-
inducing IFN-β (TRIF), and (iv) TRIF-related adapter
molecule (TRAM), whereas sterile-α and Armadillo repeat-
containing molecule (SARM) negatively regulates TRIF sig-
naling [60]. MyD88 appears to be the key adaptor molecule,
because it is required for signaling by all TLRs with only one
exception: TLR3 uses TRIF [7]. The binding of the activating
adaptors results in the subsequent recruitment of IL-1R,
associated kinases (IRAKs) and downstream activation of
transcription factors including NF-κB and IFN regulatory
factor 3 (IRF3), which in turn induces the proinﬂammatory
cytokines and type I IFNs [60].
In the intestinal mucosa, expression and localization of
PRRs on IECs and DCs diﬀer signiﬁcantly from cells of
other tissues. Primary human IECs constitutively express
TLR3 and TLR5, but only low levels of TLR2 and TLR4.
As the location of the TLRs is crucial for their function,
TLRs 1, 2, 4, 5, and 6 are expressed on the cell surface to
recognize extracellular microbes, whereas TLR3, 7, 8, and
9 are present on premature endosomes [7]. As mentioned
above, expression of TLRs on IECs is generally low and some
receptors such as TLR5 and TLR9 are located basolaterally,
thus possibly preventing an interaction with PAMPs in the
intestinal lumen [7]. However, several TLRs such as TLR2,
TLR4, TLR5, and TLR9 are expressed on the apical side of
the IECs and important for the recognition of molecules
from commensal bacteria, which is crucial to trigger innate
immune responses that are required to prevent exaggerated
adaptive immunity to the intestinal microbiota [61]. This is
an important function indicating that low-level recognition
by TLRs is necessary for protection from intestinal epithelial
injury [62].
Toll-like receptor 2 (TLR2) can interact with several
speciﬁc ligands, including bacterial lipoproteins, lipoteichoic
acids of Gram-positive bacteria such as L. monocytogenes
and yeast zymosan [7]. TLR2 can form heterodimers with
TLR1 and TLR6, thereby improving the recognition of the
target lipoteichoic acids [63]. TLR2 is expressed on the cell
surface of intestinal epithelial cells and its activation by
commensal bacteria is thought to play an important role in
the maintenance of the integrity of the intestinal epithelial
barrier [64]. TLR2 is also expressed within phagolysosomes,
thus, L. monocytogenes cells that have escaped into the host
cellcytoplasmwerenotdetectedbyTLR2.Theimportanceof
TLR2 signaling for early protection against L. monocytogenes
is, however, inconclusive. Whereas a ﬁrst study observed
that L. monocytogenes infected TLR2 deﬁcient mice were
as resistant as wild-type mice, a later study using slightly
diﬀerent experimental settings revealed a protective eﬀect of
TLR2 during early L. monocytogenes infection [65, 66].
Toll-like receptor 5 (TLR5) can bind to a protein motif
common to the ﬂagellin protein making up the ﬂagella from
many bacteria, such as L. monocytogenes. TLR5 activation
induces NF-κB and stimulates TNF production, suggesting
that TLR5 may serve as a general alarm system, when the
gastrointestinal barrier is compromised by a broad spectrum
of motile bacteria. However, activation of TLR5 located on
the apical surface of IECs by ﬂagellin leads to an increase
in the expression of antiapoptotic genes. This correlates with
the observed protective eﬀects of TLR5 signaling in epithelial
homeostasis and may suggest that under physiological
conditions ﬂagellin ligation of TLR5 located on the apical
surface of IECs does not exert an inﬂammatory response.
In contrast, ﬂagellated bacteria that interact with basolateral
TLR5 signal an invasion of the epithelium by bacteria, and
therefore induce a strong proinﬂammatory response [7].
On the other hand, ﬂagellin-deﬁcient L. monocytogenes
revealed no signiﬁcant diﬀerences in virulence in infection
experiments. This observation suggests that TLR5 mediated
signaling may not be essential for pathogenesis and adaptive
immunity after an L. monocytogenes infection in immunized
animals [67].
Toll-like receptor 9 (TLR9) recognizes the CpG motifs
present in bacterial DNA. In immune cells, TLR9 is
exclusively localized in the endosomes. In the intestine,
TLR9 was shown to be located on both, the apical and
the basolateral surface of IECs. Upon activation of TLR9,
IκBα is degraded and NF-κB is activated, again resulting
in a proinﬂammatory response. In contrast, stimulation of6 International Journal of Inﬂammation
apical TLR9 led to the accumulation of polyubiquitinated
IκBα in the cytoplasm, preventing NF-κB activation and
inﬂammation [7]. Currently, there is no clear evidence that
TLR9 actually contributes to the control of L. monocytogenes
infection; further clariﬁcation may be obtained by animals
models deﬁcient in TLR9 [6].
In conclusion, the available experimental evidence sug-
gests that TLR2 is the most relevant TLR for recogni-
tion of L. monocytogenes cells. However, as IECs show
TLR2 commensal ligand-induced activation, TLR2 is also
considered to play an important role in maintaining the
integrity of the intestinal epithelial barrier [64]. This view
is further supported by the observation of an increased
expression of both TLR2 and TLR4, in a neonatal rat
model of necrotizing enterocolitis-induced mucosal injury,
suggesting that TLR2 may promote intestinal inﬂammation
under circumstances where the epithelial barrier has been
compromised [68]. In conclusion, there is no doubt that
TLR signaling plays an important role for maintaining the
integrity and function of the intestinal epithelium during
invasion by L. monocytogenes.
NOD-like receptors (NLRs) are a group of intracellular
pattern recognition receptors, which are structurally com-
posed of an N-terminal eﬀector domain that can comprise
caspase recruitment domains (CARDs) like the NODs, or
a pyrin domain as in the case of NALPs (NAcht-, Leucine-
rich repeat, and Pyrin domain-containing proteins). Known
members of the NLR family are NOD1, NOD2, NALP1,
NALP3, neuronal apoptosis inhibitory protein-5, and the
ICE protease activating factor (IPAF) [69, 70]. In humans,
twenty-three NLRs have been identiﬁed so far, while in mice
34 NLRs are known [71]. The NLRs are critical for mucosal
innate immunity as sensors of microbial components and
cell injury in the cytoplasm [72]. They mediate proinﬂam-
matory signals through activation of caspase-1 and NF-
κB. Activation of caspase-1 leads to cleavage and activation
of proinﬂammatory cytokines, such as IL-1β and IL-18, as
well as to apoptotic cell death. Both NOD1 and NOD2
are important for the innate immune response against L.
monocytogenes, because they represent intracellular sensors
of bacterial peptidoglycan components that are thought to
enter cells by endocytosis through clathrin-coated pits [73].
While NOD1 is ubiquitously expressed in adult human
tissues, NOD2 is expressed only in leukocytes, DCs, and
epithelial cells. Activation of NOD1 and NOD2 results in
the translocation of NF-κB and mitogen-activated protein
kinase into the nucleus, to up-regulate the transcription of
proinﬂammatory genes and mediate antibacterial eﬀects by
the up-regulation of another group of small antibacterial
peptides, the defensins [7].
The nucleotide-binding oligomerization domain 1
(NOD1) recognizes a diaminopimelic acid-containing di-
peptide or tripeptide molecule generated by lysozyme action
on the peptidoglycan of many Gram-negative and Gram-
positive bacteria, including L. monocytogenes [74].
The nucleotide-binding oligomerization domain 2
(NOD2) is activated by muramyl dipeptide (MDP), which is
another degradation product of the peptidoglycan produced
by lysozyme and other (bacterial) peptidoglycan hydrolases.
In intestinal Paneth cells, NOD2-mediated signaling is
important for the expression of antimicrobial peptides, the
cryptidins, which are able to disrupt the membrane function
ofmostbacteria.NOD2-deﬁcientmicerevealedanabnormal
development and function of Peyer’s patches resulting in
increased translocation of microbes across Peyer’s patches,
and increased concentrations of cytokines such as TNF-α,
IFN-γ, IL-12, and IL-14 [75]. As a consequence, NOD2-
deﬁcient mice are highly susceptible to L. monocytogenes
infection via the oral route, but normally susceptible to
intravenous challange [76]. This observation demonstrates
the importance of NOD2 signaling to prevent infection of
the intestinal mucosa by inducing antimicrobial defensins
that play an important role in in vivo defence against
pathogens [77]. The intestinal P glycoprotein also seems to
be important for host protection against L. monocytogenes
GIT infection, most likely by inhibiting absorption of the
pathogen into enterocytes [78].
Several NLRs, together with caspase-1, form proin-
ﬂammatory multiprotein complexes termed the “inﬂam-
masomes”. After activation, the molecules assemble and
lead to multimerization of the adaptor molecule apoptosis-
associatedspeck-likeproteincontainingaC-terminalcaspase
recruitment domain (ASC). The signaling cascade results
in the processing and secretion of mature IL-1β and IL-18,
which are mediators for the activation of innate and adaptive
immune responses [6]. NLR family members known to
forminﬂammasomescompriseNALP1,NALP2,NALP3,and
NALP4.
NALP3 forms an inﬂammasome complex with ASC, car-
dinal, and procaspase-1 [79]. The NALP3 pathway is known
to be activated by L. monocytogenes infection, although the
speciﬁc ligands that activate NALP3 remain unknown. On
the other hand, L. monocytogenes DNA in the host cell
cytoplasmisknown toactasaligandforahithertounknown
PRR that mediates induction of IFN-β through activation
of interferon regulatory factor 3 (IRF3) [80]. Interestingly,
cytosolic L. monocytogenes actively increase NF-κBa c t i v i t y
by expression of the virulence factors listeriolysin O (LLO)
and internalin B (InlB). This strategy leads to an increased
proinﬂammatory response and recruitment of immune cells
to the site of infection. An interesting suggestion is that the
increased response actually promotes spread of intracellular
pathogens, by recruiting more host cells, which can serve
as potential vehicles for the pathogen [81]. Furthermore, L.
monocytogenes induces expression of type I interferon (IFN-
αβ) that are known to be essential for the immune system to
clear viral pathogens. However, in contrast to the protective
eﬀect to virus infections, in the case of L. monocytogenes the
IFN-αβ induction results in an increase in host susceptibility
to the pathogen [82]. The observed beneﬁt might be due
either to direct enhancement of bacterial growth, or more
likely,todown-modulationofapartoftheimmuneresponse
that plays an important role in controlling bacterial growth.
The latter would be supported by the observation that
induction of IFN-αβ enables L. monocytogenes to suppress
macrophage activation by IFN-γ [82]. It was also shown that
early during L. monocytogenes infection type I interferons
induceTcellapoptosis,resultingingreaterIL-10secretionbyInternational Journal of Inﬂammation 7
phagocytic cells which in turn leads to dampening the innate
immune response [83].
Autophagy contributes to innate immune defense
against various intracellular bacterial pathogens [84]. When
autophagy was discovered, it was thought to serve as a
pathway for recycling of intracellular organelles and cyto-
plasmic constituents as part of cellular homeostasis [6]. For
this purpose, a double membrane vacuole is formed around
the target object in the cytoplasma. This vacuole is then
directed to the lysosome pathway, resulting in degradation of
the vacuolar content. Similarly, intracellular bacteria can be
targeted and destroyed, as it is well known for intracellular
pathogens such as Salmonella,G r o u pAStreptococcus,o r
Mycobacterium tuberculosis [85–87]. However, other bacteria
are able to evade or even exploit autophagy during infection
[88].Pathogensadaptedtopersistenceinthecytoplasm,such
as Listeria monocytogenes and Shigella ﬂexneri,h a v ee v o l v e d
mechanisms to avoid autophagy [89, 90].
For Salmonella and Toxoplasma, it was shown that the
damaged vacuole itself triggers autophagy of the pathogens
[85, 91]. However, for Listeria monocytogenes infection
in Drosophila melanogaster, it was demonstrated that a
peptidoglycan-recognition protein, acting as an intracellular
PRR, plays an essential role for autophagy protection from
the pathogen [92]. Results from previous studies indicated
that L. monocytogenes deploy several mechanisms to evade
from autophagy [90, 93, 94], and it was speculated whether
this eﬀect is mainly due to actin-based motility, or due to
masking of the bacterial cell [93]. An earlier study suggested
that active bacterial protein synthesis is required to escape
from autophagy in macrophages [90], and results from
a more recent study led to the assumption that bacterial
phospholipases (PI-PLC and PC-PLC) may play another role
[93]. How the bacterial Plc enzymes are involved is not
entirely clear, but they are thought to either mediate escape
from the autophagosome or prevent their formation [95].
However, in a recent study, Yoshikawa et al. [96]c l e a r l y
showed that during primary infection L. monocytogenes
avoids autophagy by disguising itself as a host organelle. Due
totheabilityofActAtorecruithostcellcytoskeletonproteins
such as the Arp2/3 complex and VASP, the pathogens avoid
ubiquitination and p62 accumulation. Moreover, it was
demonstrated that lack of actin-based motility alone is not
suﬃcient to escape from autophagy.
Although L. monocytogenes was previously thought to
primarily reside in the cytoplasm, a recent study described
the presence of variant L. monocytogenes forms that replicate
in macrophages, inside large, LAMP1-positive vacuoles des-
ignated as spacious Listeria-containing phagosomes (SLAPs)
[97]. The formation of SLAPs seems to be promoted by
ineﬃcient LLO activity that is not suﬃcient for bacterial
escape from phagosomes, which triggers an autophagic
response to the damaged phagosome. On the other hand,
the LLO leads to disruption of the proton gradient, thereby
preventing fusion with lysosomes. Within the SLAPs the
bacteria are able to replicate, but the replication rate is low
compared to the cytoplasm [97, 98]. The reason for the
impaired LLO expression of bacteria in SLAPs is unknown.
However, it is known that LLO activity is low in LAMP-1
or alkaline compartments, which are the characteristics of
SLAPs [98, 99]. Moreover, function of LLO can be impaired
by innate immune responses, such as reactive oxygen and
nitrogen intermediates, and cathepsin D [100, 101]. Because
the maturation of phagosomes is quite heterogeneous, the
b a c t e r i as t u c ki nS L A P sm a yb ee ﬀected by other host innate
factors, compared to the bacteria that managed to escape
from the phagosome [95].
6. AdaptiveImmune Responses to
Listeria monocytogenes
Adaptiveimmuneresponsesfollowtheinitialinnateimmune
responses and dendritic cells (DCs) represent an important
link between the two immunological pathways [102]. DCs
respond to diﬀerent pathogens and initiate the appropriate
type of T cell response needed to control the infection. In
response to L. monocytogenes infection, DCs are critical in
priming the T cell response, since mice depleted of DCs
are unable to generate a CD8 T cell response [103]. Due to
the primarily intracellular localization of L. monocytogenes,
CD4 and CD8 T cells mediate most of the adaptive immune
response,andarecrucialforlong-termimmunityafterinitial
L.monocytogenesinfection.Othercellsubsetsmaycontribute
by inﬂuencing the CD4 and CD8 T cell responses. Whereas
innate immune cells are important for initial control of
L. monocytogenes infection, T cells are required for ﬁnal
clearance of the pathogen. Almost any cell type that harbors
L. monocytogenes in the cytoplasm can process the proteins
secreted from the pathogen, by degradation and subsequent
loading on MHC class I molecules, in order to present them
on the cell surface to CD8 T cells. Only professional antigen-
presenting cells (APCs) can present antigens derived from
lysosomal degradation via the MHC class II pathway to CD4
T cells [6]. The CD8 T cells mediate the anti-Listeria immu-
nity by two synergistic mechanisms: ﬁrst, by secretion of
IFN-γ to activate macrophages; secondly, by lysis of infected
cells via perforin and granzymes, leading to the exposure
of intracellular bacteria to the activated macrophages [104].
IFN-γ is known to be essential for host resistance to intra-
cellular pathogens such as L. monocytogenes, as it mediates
the activation of resting macrophages that more eﬃciently
restricts the multiplication of intracellular pathogens and
promotes long-term protective cellular immunity [105].
The role of CD4 T cells in the course of the control
of L. monocytogenes infection is much less well understood.
L. monocytogenes induces a strong T-helper type 1 response
and, similar to CD8 T cells, CD4 T cells also secrete IFN-γ.
The strong CD8 and CD4 T cell responses results in a stable
population of memory T cells speciﬁc for L. monocytogenes
[6].
In the intestine, NKT cells (lymphocytes expressing both
NK and T cell markers) play an important role in the
control of early infection with L. monocytogenes [106]. It was
shown that processing and presentation of listerial antigens
is mediated by a distinct population of DCs, and strong
costimulation is necessary for the development of a local
antigen-speciﬁc T cell response in the intestinal mucosa.8 International Journal of Inﬂammation
This strong costimulation seems to be required to activate
appropriate antilisterial T cells and to surmount tolerance
within the generally immunosuppressive intestinal milieu
[107].
In general, adaptive immune responses in the intestine
are characterized by high numbers of IgA producing plasma
cells, regulatory T cells, and IL-17 producing T cells whose
development is closely linked to factors produced by PRRs
expressing IECs, DCs, and macrophages. This indicates
that PRR mediated recognition of ligands produced by
commensal bacteria is involved in positive and negative
regulation of both, innate and adaptive immunity in the
intestine [7].
7.Listeria monocytogenes L-Forms
L-forms are protoplast-like variants of bacteria that lost
their ability to maintain a rigid cell wall. They have
been ﬁrst described at the beginning of the last century
and were reported for many bacterial species. After their
discovery,theyhavebeenintensivelystudiedusingnumerous
approaches [108]. However, due to the fastidious nature
of L-form bacteria and experimental diﬃculties using old-
fashioned techniques, these studies mainly focused on
morphology and physiology of L-form cells and often led
to inconclusive data. This was also the case for L-forms of
L. monocytogenes [109]. It was only recently that L-form
research experienced a renaissance, due to new experimental
systems and the application of molecular biology and state-
of-the-art imaging techniques [110–112]. In a recent study,
it was demonstrated that stable L-forms of L. monocytogenes
are viable bacteria that are not only able to survive, but also
able to replicate and multiply using a unique, previously
unknown mechanism [110]. Thus, L-forms are unlikely to
be just artifacts found under laboratory conditions, but
seem to represent a pre-programmed, alternative phenotype
of bacterial life. Of particular interest is the observation
that L. monocytogenes L-forms are able to persist within
macrophages, suggesting that they retain at least a part of
their pathogenetic traits (Schnell et al., unpublished data).
Previous results from tissue culture studies already suggested
that L-forms may be able to persist within eukaryotic
cells for various time periods [113, 114]. Clinical case
reports about the isolation of cell wall-deﬁcient variants
in cases of persistent and recurrent bacterial infection also
suggested that L-forms may serve as cryptic agents of
disease in a variety of human infectious diseases [114–
118]. Subsequent reversion to parental forms may lead
to a damage of the host cells. In the case of L-forms,
when the bacteria have completely shed their cell walls,
several proteins that represent important markers for the
human immune system are also lost. Therefore, the immune
system may no longer be able to discern and recognize
these bacteria cells. Lack of the cell wall as an important
target for antibiotic treatment represents a further threat,
due to the ineﬀectiveness of cell-wall active drugs such
as β-lactams and cephalosporins on L-form cells [110,
119].
8 .T h eP o s s i b l eR o l eo fListeria in
Inﬂammatory BowelDisease
Inﬂammatory bowel disease is a collective term for Crohn’s
disease and ulcerative colitis, both immune-mediated dis-
eases of the gastrointestinal tract which can develop in
genetically susceptible individuals [120]. A potential role
of L. monocytogenes in the pathogenesis of inﬂammatory
bowel disease (IBD) has been suggested, because interference
of the pathogen with NOD2-based signaling [121], and
variations of NOD2/CARD15 have been shown to represent
a risk factor for Crohn’s disease [122]. Especially noteworthy
seems the presence of L. monocytogenes at the site of
colon perforation in a patient with fulminant ulcerative
colitis [123]. Another study, however, reported an equal
prevalence of L. monocytogenes in patients suﬀering from
IBD and non-IBD control patients [124], suggesting a
more common occurrence of the pathogen in the gas-
trointestinal environment. Together with the observation
of a low prevalence of L. monocytogenes in biopsies from
IBD patients the available data do not yet support a
role of L. monocytogenes in IBD [120]. However, there is
still a lot to be done to unravel any potential indirect
involvement of L. monocytogenes in the pathogenesis of
IBD.
Listeria monocytogenes has been employed for decades as
a model organism to study host-pathogen interactions and
immuneresponsesagainstintracellularpathogens[125].The
many studies provide signiﬁcant insight into how L. mono-
cytogenes interacts on host mucosal surfaces of the human
gastrointestinal tract with the immune system that triggers
theantibacterialimmuneresponses.Despitethevastamount
of knowledge gathered on the host-pathogen interactions
and the bacterial adaptations to mammalian host, it was only
recently that L. monocytogenes was found to be responsible
for induction of local mucosal inﬂammation in immuno-
competent individuals, resulting in febrile gastroenteritis
[4]. Hence, the availability of new and improved animal
models, such as a humanized mouse model [49], will be an
important prerequisite to improve the investigation of the
gastrointestinal phase of L. monocytogenes infection, in order
to further enhance our understanding of the interaction
and the interplay of the pathogen with the host intestinal
mucosa.
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